Clinical Trial: A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630545) titled 'A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.' on May 06.

Brief Summary: The goal of this study is to learn if MTX325 can be developed as a potential disease-modifying treatment for Parkinson's Disease.

Study Start Date: Nov. 30, 2023

Study Type: INTERVENTIONAL

Condition: Parkinson's Disease (PD) Mild to Moderate Parkinson's Disease Early Stage Parkinson's Disease

Intervention: DRUG: MTX325

MTX325

OTHER: Placebo

Placebo

Recruitment Status: RECRUITING

Sponsor: Mission Therapeutics

Disclaimer: Curated by HT Syndication....